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Objective: The objective of this study was to investigate selenium and glutathione levels in pulmonary tuberculosis 
patients and controls in Malawi. 
Methods: The case-control study included 19 patients and 15 apparently healthy controls for whom, levels of selenium 
and glutathione were measured. 
Results: The plasma selenium levels were significantly lower in tuberculosis patients compared with the controls (p = 
0.02).  




Both protein-energy malnutrition and deficiencies in 
micronutrients are associated with a significant 
impairment of various interactions and functions of the 
cell-mediated immune system (1). A study in Malawi 
showed that selenium deficiency occurred in 87 % of 
tuberculosis (TB) patients (2) while a study in Ethiopia, 
on antioxidants status in untreated TB patients, showed 
that the patients were deficient in glutathione (GSH) 
compared to healthy controls (3). Selenium via 
selenoproteins and GSH are important endogenous 
antioxidants that protect against oxidative damage and 
regulate immune functions (4, 5). The objective of this 
study was thus to investigate plasma levels of selenium 




A case-control study was conducted in Malawi between 
September and December 2006.   Fifty-four patients were 
asked to participate of whom 42 accepted. Fifteen 
patients did not have follow-up samples, 6 withdrew the 
consent without any reason and data from 2 patients was 
not included due to inappropriate sample collection. For 
the controls, 47 were asked to participate and 25 
consented. Six controls did not have follow–up samples 
and 4 withdrew the consent without any reason. The final 
sample set consisted of 19 patients and 15 controls aged 
15-55 years. 
 
TB was confirmed when a patient was smear-positive on 
at least two of three sputum specimens. The study was 
done 2-8 weeks after onset of treatment because then 
they had resumed their ordinary diet. Patients with a 
previous history of TB and extra pulmonary TB patients 
were excluded. Controls were randomly selected 
according to the “random-walk method” (6). Matching of 
age and sex was done and adjusted for the statistical 
analysis. 
 
Ethical clearance was obtained from the Regional 
Committee for Medical Research Ethics, Norway and the 
Malawi College of Medicine Research Ethics Committee, 
Malawi. Participants were enrolled after signing a written 
informed consent form. 
 
Statistical analysis was done using SPSS for Windows 
14.0 (Statistical Package for the Social Sciences, 
Chicago, IL, USA) 
 
Procedure for Blood Testing  
Seven ml blood was drawn into tubes containing heparin 
from non-fasting participants. Two ml blood was then 
transferred to an eppendorf vial containing 50 µl 2.0 M 
serine borate buffer for glutathione measurements. Blood 
samples were protected from bright light.  
 
The samples were stored for 40-43 minutes and then 
centrifuged in Labofuge 200 (Osterode, Germany) at 
2500 g for 10 minutes. All samples were frozen at -20 ºC 
for 3 weeks and then at -80 ºC until transferred on dry ice 
to Norway for analysis. The procedure for GSH analysis 
has been described by Bohn et al. (7). Selenium was 
measured with PerkinElmer, (Elan® DRC™ II 
Inductively Coupled Plasma Mass Spectrometry 
instrument, Concord, Canada). 
 
Results 
Characteristics of study participants are shown in table 1. 
Adjusting for age and sex, TB patients had significantly 
lower levels of selenium compared to the controls (p = 
0.02). No significant difference was observed for GSH (p 
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Table 1:  Characteristics of the study group, mean values of Selenium and GSH levels in 
Patients and controls** and multivariate linear regression analysis in both groups* 
 TB 
patients 




n = 15 
n (%) 
Coefficient 95% CI  P-value 
Women  6 5    
Men 13 10    
Age, years, 
mean [SD] 
28.0±7.0 32.1±10.5    
Illiterate 5 (26) 5 (33)    











1.10±0.22 1.23±0.19   0.10 
GSH** (µmol/L) 3.85±1.68 4.48 ±1.52   0.29 
Group* 
(selenium)  
  -0.17 -0.31-0.02 0.02 
Group * 
(GSH)   
  -0.53 -1.81-0.73 0.39 
**Mean±Standard deviation [SD] GSH=Glutathione 
*Adjusted for age and sex. CI= Confidence Interval 
 
Discussion  
After adjusting for age and sex, selenium concentration 
in TB patients was 0.22 µmol/L lower than the controls 
(p = 0.02). The difference is significant and in agreement 
with Kassu et al. (8). The concentration of GSH in TB 
patients was 0.53 µmol/L lower than the controls (p = 
0.39). This result is not in agreement with results found 
in Ethiopia (3) where the GSH concentrations were 
significantly lower in TB patients. The possible 
explanations could be the degradation of GSH by enzyme 
gamma-glutamyl transferase during sample collection 
and preparation (9), small sample size and selection bias. 
We have avoided degradation of GSH by using serine 
borate buffer that inhibits enzyme gamma-glutamyl 
transferase (9). 
 
Selenium is a trace mineral, involved in several key 
metabolic activities via selenoproteins. These enzymes 
are essential to protect against oxidative damage and to 
regulate immune functions (4). GSH is an antioxidant 
and protects cells from toxic effects of reactive oxygen 
species. It plays an important role in regulating the 
cellular immunity and protects against mycobacteria (5). 
The reason for lower selenium and GSH levels in TB 
patients is unclear, but could be explained by the 
increased oxidative stress and the reduced levels of 
antioxidant capacity found in this group (3). Other factors 
like variation in diet, absorption, the severity of the 
disease and being HIV positive may also have influenced 
the plasma levels of selenium and GSH. 
 
Limitations of the study were the small sample size and 
no statistical correction for HIV status in both groups. 
Further studies are hence needed to understand the 





This study showed that TB patients had lower plasma 
levels of selenium compared with controls.  
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